(HealthDay)—For patients with advanced renal cell carcinoma (aRCC), those initiating treatment with nivolumab plus ipilimumab versus sunitinib have longer treatment-free survival (TFS), according to a study published online ...
Dec 3, 2021
0
9
Researchers at Mass Eye and Ear and Mass General Hospital have developed a blood test, or liquid biopsy, for head and neck cancer associated with the human papilloma virus (HPV) that was shown in a new study to be more accurate, ...
Dec 2, 2021
0
2
Doctors and scientists from the German Cancer Research Center (DKFZ) and from Heidelberg University's Medical Faculty Mannheim have successfully tested a neoantigen-specific transgenic immune cell therapy for malignant brain ...
Nov 15, 2021
0
12
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients ...
Nov 10, 2021
0
2
In order for cancer cells to develop into a severe tumor, they need to be able to escape attack by the patient's own immune system. This is why immunotherapeutic treatment that helps the immune system to find and fight cancer ...
Nov 5, 2021
0
1
Researchers at the University of British Columbia (UBC) and BC Cancer, in partnership with BC Children's Hospital Research Institute (BCCHR), have developed a new test to more easily diagnose medulloblastoma, the most common ...
Nov 1, 2021
0
12
Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy. Researchers at the University of Alabama at Birmingham have now shown—in preclinical experiments—how ...
Oct 28, 2021
0
31
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing ...
Oct 11, 2021
0
74
Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism operates requires revision, according to a study published in Clinical Cancer Research.
Sep 30, 2021
0
39
Princess Margaret Cancer Centre researchers have made new findings that greatly improve detection of the human papillomavirus (HPV) in the bloodstream and could further hone precision treatment of the illness.
Sep 27, 2021
0
71
